TCTMD

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

The 2011 focused update was published online March 28, 2011, ahead of print in the Journal of the American College of Cardiology and Circulation. The writing committee, led by R. Scott Wright, MD, of ...
National Institute for Health and Care Excellence

Acute coronary syndromes

This guideline covers the early and longer-term (rehabilitation) management of acute coronary syndromes. These include ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation ...
Healio

Coronary Artery Disease - Unstable Angina/Non-STEMI Topic Review

The acute coronary syndromes include unstable angina, non-ST segment elevation myocardial infarction and ST segment elevation myocardial infarction. The terms “transmural,” “non-transmural,” “Q wave ...
TCTMD

Registry Finds Overall Decrease in Post-PCI Bleeding but Not in STEMI

Bleeding rates are steadily dropping after both elective and emergent percutaneous coronary intervention (PCI), according to registry data published in the May 22, 2012, issue of the Journal of the ...
Monthly Prescribing Reference

Aspirin Still First-Line Therapy for Unstable Angina/NSTEMI

Characteristics of STEMI Reperfusion Systems Identified Aspirin is still the first line of therapy for patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and ticagrelor ...
FiercePharma

Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial I

PARSIPPANY, N.J. and INDIANAPOLIS, March 29, 2011 /PRNewswire/ -- Oral antiplatelet therapy Effient® (prasugrel) has been added to the updated clinical practice guidelines as a Class I recommended ...
Forbes

Ticagrelor Joins Clopidogrel And Prasugrel In Updated NSTEMI Guidelines

Ticagrelor (Brilinta, AstraZeneca) gains equal standing with prasugrel (Effient, Lilly) and clopdiogrel in the newly released focused update of the ACCF/AHA guidelines for unstable angina and ...
Healio

Guideline update for unstable angina, non-STEMI addresses newly approved drugs

Please provide your email address to receive an email when new articles are posted on . Updated guidelines from the American College of Cardiology Foundation/American Heart Association Task Force on ...
FiercePharma

NICE draft guidance recommends rivaroxaban (Xarelto) to prevent blood clots in people who have had a heart attack

In draft guidance published today for consultation, NICE has recommended rivaroxaban (Xarelto, Bayer Healthcare) as an option for preventing blood clots in people who have had a heart attack as a ...
Medscape

Excess Unfractionated Heparin Dosing for STEMI and NSTEMI

(1) How was this issue identified? Starting in quarter 1 2007, we noticed the high rate of excess dosing for heparin on our ACTION site reports compared to national rates. (2) What did you do to ...
National Institute for Health and Care Excellence

Acute coronary syndromes

This guideline covers the early and longer-term (rehabilitation) management of acute coronary syndromes. These include ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation ...
Pharmabiz

Effient added to updated ACCF/AHA clinical guidelines for ACS-PCI patients with unstable angina & NSTEMI

Oral anti-platelet therapy Effient (prasugrel) has been added to the updated clinical practice guidelines as a class I recommended treatment option for patients undergoing Percutaneous Coronary ...